Andrea Cancemi started his bachelor degree in Biology at the University of Palermo in 2012, period at which he also had the opportunity to join the laboratory of Applied Microbiology at University of Warsaw, entering in contact with Biochemistry techniques.
In 2015 he followed the master course in Molecular Biology and Genetics at University of Pavia. This year he joined the laboratory of Molecular Cardiology in Pavia headed by Professor S. Priori where he started his master thesis on gene therapy, targeting the dominant form of Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT).
In 2017 he started his PhD thesis at the laboratory of Professor S. Priori at the Spanish National Centre for Cardiovascular Research (CNIC) in Madrid. He is currently investigating on the pathophysiologic mechanisms implicated on the recessive forms of CPVT.